Article Figures & Data
Tables
SVTP Patients Control Group Follow-up and Outcome No. (%) 95% CI No. (%) 95% CI Absolute Difference % (95% CI) CI=confidence interval; NA = not applicable; SVTP = superficial venous thrombophlebitis. Patients with incomplete follow-up 34 (12) 8–16 84 (15) 12–18 −3 (−8 to 2) Deaths within 24 months after index date 16 (6) 3–9 19 (3) 2–5 2 (−1 to 5) Patients with newly diagnosed cancer within 24 months after index date 5 (2) 1–5 10 (2) 1–4 0 (−2 to 2) Recurrent SVTP in patients without cancer at study entry 18 (7) 4–11 NA NA NA SVTP Group Control Group SVTP=superficial venous thrombophlebitis. a N=6 cases. b N = 2 cases. Myelodysplastic syndrome Breast carcinomaa Urothelial cell carcinoma, bladder Bronchial carcinoma Pancreatic carcinoma Urothelial cell carcinoma, bladder Ovarian carcinoma Unknown primary originb Gallbladder carcinoma
Additional Files
The Article in Brief
Idiopathic Superficial Thrombophlebitis and the Incidence of Cancer in Primary Care Patients
Frederiek F. van Doormaal , and colleagues
Background It is commonly believed that superficial venous thrombophlebitis (SVTP), or superficial blood clots, is associated with accompanying cancer. This study examines the incidence of cancer during a 2-year follow up period after a first episode of SVTP in a large general practice population.
What This Study Found Researchers found no increased incidence of cancer after a first episode of unprovoked SVTP. In this study, during the 2-year observation period after an episode of unprovoked SVTP, the rate of cancer was 2 percent, compared with 2 percent in a control group. Recurrent SVTP was not common in the study sample.
Implications
- A first episode of unprovoked SVTP diagnosed by a family physician is not associated with an increased risk of cancer in the next 2 years.